These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 33060414)
1. The Efficacy of Atropine Combined With Orthokeratology in Slowing Axial Elongation of Myopia Children: A Meta-Analysis. Gao C; Wan S; Zhang Y; Han J Eye Contact Lens; 2021 Feb; 47(2):98-103. PubMed ID: 33060414 [TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of 0.01% atropine alone or combined with orthokeratology for children with myopia: A meta-analysis. Wang Z; Wang P; Jiang B; Meng Y; Qie S; Yan Z PLoS One; 2023; 18(7):e0282286. PubMed ID: 37494360 [TBL] [Abstract][Full Text] [Related]
3. The effect of 0.01% atropine and orthokeratology on ocular axial elongation for myopia children: A meta-analysis (a PRISMA-compliant article). Yu Y; Liu J Medicine (Baltimore); 2022 May; 101(18):e29191. PubMed ID: 35550467 [TBL] [Abstract][Full Text] [Related]
4. Combined Orthokeratology with Atropine for Children with Myopia: A Meta-Analysis. Wang S; Wang J; Wang N Ophthalmic Res; 2021; 64(5):723-731. PubMed ID: 32781450 [TBL] [Abstract][Full Text] [Related]
5. Orthokeratology for Slowing Myopia Progression in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Tang K; Si J; Wang X; Lu X; Bi H Eye Contact Lens; 2023 Sep; 49(9):404-410. PubMed ID: 37284749 [TBL] [Abstract][Full Text] [Related]
6. Low concentration atropine combined with orthokeratology in the treatment of axial elongation in children with myopia: A meta-analysis. Yang N; Bai J; Liu L Eur J Ophthalmol; 2022 Jan; 32(1):221-228. PubMed ID: 33678055 [TBL] [Abstract][Full Text] [Related]
7. Efficacy, Safety and Acceptability of Orthokeratology on Slowing Axial Elongation in Myopic Children by Meta-Analysis. Li SM; Kang MT; Wu SS; Liu LR; Li H; Chen Z; Wang N Curr Eye Res; 2016 May; 41(5):600-8. PubMed ID: 26237276 [TBL] [Abstract][Full Text] [Related]
8. The effect of 0.01% atropine on ocular axial elongation for myopia children: A protocol for systematic review and meta-analysis. Gao Y; Yu Y Medicine (Baltimore); 2022 Jun; 101(22):e29409. PubMed ID: 35665735 [TBL] [Abstract][Full Text] [Related]
9. Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results. Kinoshita N; Konno Y; Hamada N; Kanda Y; Shimmura-Tomita M; Kakehashi A Jpn J Ophthalmol; 2018 Sep; 62(5):544-553. PubMed ID: 29974278 [TBL] [Abstract][Full Text] [Related]
10. Adjunctive effects of orthokeratology and atropine 0.01% eye drops on slowing the progression of myopia. Zhou H; Zhao G; Li Y Clin Exp Optom; 2022 Jul; 105(5):520-526. PubMed ID: 34228946 [TBL] [Abstract][Full Text] [Related]
11. Higher order aberrations and axial elongation in combined 0.01% atropine with orthokeratology for myopia control. Vincent SJ; Tan Q; Ng ALK; Cheng GPM; Woo VCP; Cho P Ophthalmic Physiol Opt; 2020 Nov; 40(6):728-737. PubMed ID: 32888318 [TBL] [Abstract][Full Text] [Related]
12. Interventions to slow progression of myopia in children. Walline JJ; Lindsley KB; Vedula SS; Cotter SA; Mutti DO; Ng SM; Twelker JD Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004916. PubMed ID: 31930781 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of the Euclid orthokeratology lens in slowing axial elongation. Bullimore MA; Liu M Cont Lens Anterior Eye; 2023 Oct; 46(5):101875. PubMed ID: 37365049 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Administration of 0.02% Atropine and Orthokeratology for Myopia Control. Lyu Y; Ji N; Fu AC; Wang WQ; Wei L; Qin J; Zhao BX Eye Contact Lens; 2021 Feb; 47(2):81-85. PubMed ID: 32443010 [TBL] [Abstract][Full Text] [Related]
15. Combination of orthokeratology lens with 0.01% atropine in slowing axial elongation in children with myopia: a randomized double-blinded clinical trial. Yu S; Du L; Ji N; Li B; Pang X; Li X; Ma N; Huang C; Fu A BMC Ophthalmol; 2022 Nov; 22(1):438. PubMed ID: 36380280 [TBL] [Abstract][Full Text] [Related]
16. The synergistic efficacy and safety of combined low-concentration atropine and orthokeratology for slowing the progression of myopia: A meta-analysis. Zheng NN; Tan KW Ophthalmic Physiol Opt; 2022 Nov; 42(6):1214-1226. PubMed ID: 35919929 [TBL] [Abstract][Full Text] [Related]
17. A new look at the myopia control efficacy of orthokeratology. Santodomingo-Rubido J; Cheung SW; Villa-Collar C; Cont Lens Anterior Eye; 2024 Oct; 47(5):102251. PubMed ID: 38906728 [TBL] [Abstract][Full Text] [Related]
18. Difference in the effect of orthokeratology on slowing teen myopia with different years of follow-up. Meng Z; Shuo G; Guohu D; Wei Z; Jingyi L; Yuanchao C; Zhaodong L; Changhong Y J Fr Ophtalmol; 2022 Sep; 45(7):718-727. PubMed ID: 35577700 [TBL] [Abstract][Full Text] [Related]
19. Adjunctive effect of orthokeratology and low dose atropine on axial elongation in fast-progressing myopic children-A preliminary retrospective study. Chen Z; Huang S; Zhou J; Xiaomei Q; Zhou X; Xue F Cont Lens Anterior Eye; 2019 Aug; 42(4):439-442. PubMed ID: 30482510 [TBL] [Abstract][Full Text] [Related]
20. Combined 0.01% atropine with orthokeratology in childhood myopia control (AOK) study: A 2-year randomized clinical trial. Tan Q; Ng AL; Cheng GP; Woo VC; Cho P Cont Lens Anterior Eye; 2023 Feb; 46(1):101723. PubMed ID: 35654683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]